Skip to main content
Fig. 2 | Biology Direct

Fig. 2

From: Long non-coding RNA LINC00426 contributes to doxorubicin resistance by sponging miR-4319 in osteosarcoma

Fig. 2

LINC00426 inhibition re-sensitized OS cells to doxorubicin. a The relative expression level of LINC00426 in doxorubicin-resistant MG63 (MG63/DXR) and KHOS (KHOS/DXR) cells transfected with LINC00426 siRNAs (si-LINC00426–1, si-LINC00426–2) or negative control siRNA (si-NC) was detected by qRT-PCR. b and c Cell counting kit-8 assays were performed to examine the cell proliferation rate of MG63/DXR and KHOS/DXR cells in response to doxorubicin after LINC00426 knockdown. d Clone formation assays were performed to examine cell vitality of MG63/DXR and KHOS/DXR cells to doxorubicin exposure (10 μg/ml, 14 days) after LINC00426 knockdown. e IC50 values of MG63/DXR and KHOS/DXR cells transfected with LINC00426 siRNAs (si-LINC00426–1, si-LINC00426–2) greatly decreased compared with those of the negative control siRNA (si-NC) group. f Caspase-3 activity assays were performed to examine cell apoptosis of MG63/DXR and KHOS/DXR cells to doxorubicin exposure (0.1 μg/ml, 48 h) after LINC00426 knockdown. The data represent the mean ± SD. Two-way ANOVA for B and C, Student’s t-tests for others. *P < 0.05; **P < 0.01; ***P < 0.001

Back to article page